Surprisingly, while IRF-1 causes growth inhibition and cell death in BC cells by down-regulating molecules involved in the NF-κB pathway, the same effect was not observed in non-malignant human breast cells, reflecting the specificity of IRF1 (51). This evidence concerns the gene NFKB1 and breast cancer.